Lantern Pharma Inc.
LTRN
$1.79
$0.021.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -53.71% | -67.94% | -57.86% | -55.93% | -52.19% |
| Total Receivables | -- | -- | -69.07% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -37.81% | -74.07% | -42.52% | -21.96% | -14.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 31.71% | 9.28% | -- | -69.92% | -60.64% |
| Total Current Assets | -50.82% | -66.11% | -57.21% | -55.01% | -51.26% |
|
|
|||||
| Total Current Assets | -50.82% | -66.11% | -57.21% | -55.01% | -51.26% |
| Net Property, Plant & Equipment | -65.81% | -64.06% | -62.60% | -61.53% | -30.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 120.44% | 120.44% | 241.14% | 0.00% | 14.69% |
| Total Assets | -50.62% | -65.76% | -56.84% | -55.02% | -51.05% |
|
|
|||||
| Total Accounts Payable | -0.68% | -4.33% | 26.81% | 20.06% | 39.24% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -69.81% | -63.41% | -58.86% | -52.36% | -19.82% |
| Total Finance Division Other Current Liabilities | -32.34% | -23.35% | -21.16% | 3.63% | -31.45% |
| Total Other Current Liabilities | -32.34% | -23.35% | -21.16% | 3.63% | -31.45% |
| Total Current Liabilities | -11.50% | -11.87% | 3.93% | 12.19% | 6.16% |
|
|
|||||
| Total Current Liabilities | -11.50% | -11.87% | 3.93% | 12.19% | 6.16% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -75.32% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 141.32% | -12.56% | 2.68% | 9.34% | 5.21% |
|
|
|||||
| Common Stock & APIC | 3.08% | 2.83% | 2.67% | 1.90% | 0.81% |
| Retained Earnings | -21.97% | -19.75% | -22.52% | -26.97% | -29.32% |
| Treasury Stock & Other | -182.92% | -127.03% | -83.51% | 259.29% | 827.27% |
| Total Common Equity | -125.69% | -79.46% | -69.16% | -63.96% | -59.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -125.69% | -79.46% | -69.16% | -63.96% | -59.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -125.69% | -79.46% | -69.16% | -63.96% | -59.52% |
|
|
|||||